Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11214359 | 0.88 | KCNH2 (0.46) | SIGMAR1 | |
| SCHEMBL11160967 | 0.87 | DRD1 (0.47) | LMNAPOLBTDP1DRD4 | |
| SCHEMBL11215748 | 0.84 | CYP2D6 (0.41) | MEN1KMT2APOLBSIGMAR1 | |
| Fumaric Acid SCHEMBL11169280 | 0.82 | MEN1 (0.43) | MEN1KMT2ALMNAPOLBTDP1 | |
| Fumaric Acid SCHEMBL11169294 | 0.82 | MEN1 (0.43) | MEN1KMT2ALMNAPOLBTDP1 | |
| SCHEMBL11167197 | 0.80 | ALDH1A1 (0.45) | MEN1KMT2APOLB | |
| SCHEMBL11214362 | 0.79 | LMNA (0.40) | MEN1KMT2ALMNAPOLBTDP1 | |
| SCHEMBL11171000 | 0.78 | DRD1 (0.38) | MEN1KMT2ALMNAPOLBTDP1 | |
| SCHEMBL11160646 | 0.78 | GAA (0.47) | MEN1KMT2A | |
| Bromide SCHEMBL11156560 | 0.77 | MEN1 (0.42) | MEN1KMT2ALMNADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0080012-A1 | 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate | SMITHKLINE BECKMAN CORPORATION (US) | 1983-06-01 | — | — | EP | disclosed |
| EP-0007070-B1 | 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY | SMITHKLINE BECKMAN CORPORATION (US) | 1983-01-19 | — | — | EP | disclosed |
| US-4265890-A | ANTIPSYCHOTIC, ANTIEMETICS | SMITHKLINE CORPORATION (US) | 1981-05-05 | — | — | US | disclosed |
| EP-0007070-A1 | 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity | SMITHKLINE BECKMAN CORPORATION (US) | 1980-01-23 | — | — | EP | disclosed |